BioCryst Pharmaceuticals, Inc. (FRA:BO1)
Germany · Delayed Price · Currency is EUR 6.66
+0.30 (4.78%)
Last updated: Jan 8, 2026, 8:08 AM CET
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of €1.34 billion as of January 9, 2026. Its market cap has decreased by -13.58% in one year.
Market Cap
1.34B
Enterprise Value
1.74B
Revenue
511.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.66
Market Cap Chart
Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 19.07M to 1.34B, an increase of 6,922.39%. That is a compound annual growth rate of 14.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.34B | -4.24% |
| Dec 31, 2025 | 1.40B | -7.03% |
| Dec 31, 2024 | 1.50B | 35.56% |
| Dec 29, 2023 | 1.11B | -44.58% |
| Dec 30, 2022 | 2.00B | -8.62% |
| Dec 31, 2021 | 2.19B | 103.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |